Rallybio
RLYB
59 hedge funds and large institutions have $188M invested in Rallybio in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 5 closing their positions.
130% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 10
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
11% more funds holding
Funds holding: 53 → 59 (+6)
3% more capital invested
Capital invested by funds: $183M → $188M (+$4.87M)
0.47% more ownership
Funds ownership: 10.54% → 11.01% (+0.47%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.42M |
| 2 |
Mariner
Overland Park,
Kansas
|
+$3.6M |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.34M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$794K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$419K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
CHI Advisors
New York
|
-$1.33M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.08M |
| 3 |
Vontobel Holding
Zurich,
Switzerland
|
-$1M |
| 4 |
CCM
CAAS Capital Management
New York
|
-$814K |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$503K |
RLYB Hedge Fund Activity: Q2 2023 in Review
59 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q2 2023, worth a combined $188M — up 2.7% from $183M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new RLYB positions and 5 closed out — a net gain of 6 holders — while 23 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, adding an estimated $4.42M. The largest seller was CHI Advisors, cutting an estimated $1.33M.
- 59 institutional investors held Rallybio (RLYB) as of Q2 2023, up from 53 in Q1 2023.
- Funds reported $188M of Rallybio stock for Q2 2023, up 2.7% quarter-over-quarter.
- 11 funds opened new Rallybio positions in Q2 2023 and 5 closed out, a net change of +6 holders.
- The largest Rallybio buyer in Q2 2023 was BlackRock, an estimated $4.42M added.
- The largest Rallybio seller in Q2 2023 was CHI Advisors, an estimated $1.33M sold.
Based on aggregated 13F filings for Q2 2023.